Journal ArticleOPEN ACCESS

Efficacy and safety of sitagliptin as a third therapeutic agent in the treatment of type 2 diabetes mellitus

  • Hayati F
  • Hazim A
  • Sasongko T
  • et al.
Journal of Diabetes Research and Clinical Metabolism (2014) 3(1) 10
DOI: 10.7243/2050-0866-3-10
N/ACitations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Abstract\rBackground: Information on sitagliptin as a third line agent in combination with other antidiabetic agents is still lacking. This study evaluated the safety and efficacy of sitagliptin as an add-on therapyin

Cite

CITATION STYLE

APA

Hayati, F., Hazim, A., Sasongko, T. H., Siew Hua, G., Wan Mohamed, W. M. I., Daud, J., … Wan Bebakar, W. M. (2014). Efficacy and safety of sitagliptin as a third therapeutic agent in the treatment of type 2 diabetes mellitus. Journal of Diabetes Research and Clinical Metabolism, 3(1), 10. https://doi.org/10.7243/2050-0866-3-10

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free